Page 33 - Immunizations News Today

By Anthony O. Goriainoff GSK said Monday that its shingles vaccine Shingrix has been approved by Japan's Health, Labor and Welfare Ministry, or MHLW, for the...

As if dirty vaccines don’t do enough damage to the human race, now the manufacturing of them is depleting the horseshoe crab population to use their bright blue blood for capturing bacteria in blood clots. That’s right, the pharmaceutical industry couldn’t care less about the environment, as they flog the horseshoe crab species for their […]

A key committee backed a policy saying adults 65 and older "may receive" the shots, rather than one saying the injections "are recommended."

The CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.

The Advisory Committee on Immunization Practices stopped short of recommending the vaccines for everyone age 65 and above.

There is a reason why Baylor College of Medicine dean and pediatrician Peter Hotez refuses to debate 2024 presidential contender Robert F. Kennedy Jr. on the issue of vaccines: because he knows he would lose – and because Hotez is directly connected to the creation of the Wuhan coronavirus (Covid-19) and other chimeric coronaviruses in […]

By Elena Vardon GSK on Wednesday said that Phase 3 trial results for its Arexvy respiratory syncytial virus vaccine for older adults showed positive data....

The CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.

A federal advisory panel recommended that the next batches of COVID-19 vaccines focus on XBB variants, while questioning how often younger people in good health would need additional shots.

The FDA advisory panel's recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.